VEGFR1 and VEGFR2 in lip carcinogenesis and its association with microvessel density

被引:11
|
作者
Ariotti, Carla [1 ]
Wagner, Vivian Petersen [1 ]
Salvadori, Gabriela [2 ]
Carrard, Vinicius Coelho [1 ]
Trevizani Martins, Marco Antonio [3 ]
da Cunha Filho, Joao Julio [4 ]
Meurer, Luise [5 ]
Martins, Manoela Domingues [1 ,3 ]
机构
[1] Univ Fed Rio Grande do Sul, Dept Oral Pathol, Sch Dent, Porto Alegre, RS, Brazil
[2] Univ Oslo, Fac Dent, Inst Oral Biol, Oslo, Norway
[3] Hosp Clin Porto Alegre HCPA UFRGS, Dept Oral Med, Porto Alegre, RS, Brazil
[4] Univ Fed Rio Grande do Sul, Dept Oral Surg, Sch Dent, Porto Alegre, RS, Brazil
[5] Univ Fed Rio Grande do Sul, Sch Med, Dept Pathol, Porto Alegre, RS, Brazil
关键词
Oral squamous cell carcinoma; Actinic cheilitis; Potentially malignant disorders; Vascular endothelial growth factor; Angiogenesis; ENDOTHELIAL GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMA; IMMUNOHISTOCHEMICAL EXPRESSION; TUMOR ANGIOGENESIS; NECK-CANCER; PROGNOSTIC-SIGNIFICANCE; FACTOR RECEPTORS; ORAL-CANCER; HEAD; PROGRESSION;
D O I
10.1007/s13277-015-3454-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of the present study was to determine the role of vascular endothelial growth factor receptors (VEGFR1 and VEGFR2) in lip carcinogenesis, to investigate correlations between these markers with microvessel density (MVD) and clinicopathological aspects. Medical records from 27 cases of actinic cheilitis (AC) and 46 cases of lower lip squamous cell carcinoma (LLSCC) were analysed and submitted to immunohistochemistry. VEGFR1- and VEGFR2-immunostained sections were analysed based on percentage of positive epithelial and inflammatory cells, while CD31 was submitted to quantitative analysis to determine MVD. Different patterns of VGFR1 and VEGFR2 expression were observed between AC and LLSCC. VEGFR1 expression in epithelial and inflammatory cells and VEGFR2 expression in epithelial cells were higher in AC compared to LLSCC (p < 0.05). VEGFR1 expression in epithelial cells was higher in LLSCC compared to AC (p < 0.001). Expression of both receptors was not associated to MVD or clinicopathological aspects. A direct correlation was found between epithelial VEGFR1 and VEGFR2 expression (p = 0.02) and between VEGFR2 epithelial and inflammatory expression (p < 0.001). Our findings indicate that activation of VEGFR1 and VEGFR2 in epithelial and inflammatory cells appears to be an early event in lip carcinogenesis.
引用
收藏
页码:7285 / 7292
页数:8
相关论文
共 50 条
  • [1] Microvessel density and immunohistochemical expression of angiogenic proteins VEGF, VEGFR1 and VEGFR2 in gastric adenocarcinoma
    Lampri, Evangeli
    Goussia, Ann
    Sintou-Mantela, Evdoxia
    Balasi, Eufemia
    Charchanti, Antonia
    Kamina, Sevasti
    Capizzelo, Antonio
    Tsekeris, Pericles
    Briasoulis, Evangelos
    Malamou-Mitsi, Vasiliki
    Agnantis, Niki J.
    Bai, Maria
    VIRCHOWS ARCHIV, 2007, 451 (02) : 321 - 321
  • [2] Microvessel density and immunohistochemical expression of the angiogenic proteins VEGF, VEGFR1 and VEGFR2 in normal, hyperplastic and neoplastic endometrium
    Zagorianakou, Nektaria
    Goussia, Ann
    Zagorianakou, Panayiota
    Pakos, Emilios
    Tsekeris, Perikles
    Nesseris, Ioannis
    Malamou-Mitsi, Vasiliki
    Agnantis, Niki J.
    Bai, Maria
    VIRCHOWS ARCHIV, 2007, 451 (02) : 501 - 501
  • [3] VEGF, VEGFR1, and VEGFR2 expression in melanoma
    Mehnert, J. M.
    McCarthy, M. M.
    Aziz, S. A.
    Sznol, M.
    Flaherty, K. T.
    Camp, R. L.
    Rimm, D. L.
    Kluger, H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] VEGFR1 and VEGFR2 in Alzheimer's Disease
    Harris, Rachel
    Miners, James Scott
    Allen, Shelley
    Love, Seth
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 61 (02) : 741 - 752
  • [5] VEGF, VEGFR1 and microvessel density in papillary thyroid cancer
    Ivanova, K.
    Ananiev, J.
    Onal, E.
    Vlaykova, T.
    Gulubova, M.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 150 - 150
  • [6] Expression of VEGF and Its receptors VEGFR1/VEGFR2 Is Associated with Invasiveness of Bladder Cancer
    Kopparapu, Pradeep Kumar
    Boorjian, Stephen A.
    Robinson, Brian D.
    Downes, Martin
    Gudas, Lorraine J.
    Mongan, Nigel P.
    Persson, Jenny L.
    ANTICANCER RESEARCH, 2013, 33 (06) : 2381 - 2390
  • [7] Association of VEGFR1, VEGFR2 and VEGFR3 polymorphisms with esophageal cancer risk: a case-control study
    Walia, Sukhpreet Kaur
    Sambyal, Vasudha
    Sudan, Meena
    Uppal, Manjit Singh
    Guleria, Kamlesh
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2024, 25 (01)
  • [8] Activation of VEGFR1 potentiates the activity of the VEGFR2: A model for a biological transistor
    Waltenberger, J
    Kranz, A
    Kroll, J
    Kliche, S
    Mayr, U
    Meyer, N
    Autiero, M
    Conway, E
    Dehio, C
    Collen, D
    Carmeliet, P
    CIRCULATION, 2001, 104 (17) : 140 - 140
  • [9] Suppression of migratory and metastatic pathways via blocking VEGFR1 and VEGFR2
    Sadremomtaz, Afsaneh
    Kobarfard, Farzad
    Mansouri, Kamran
    Mirzanejad, Laleh
    Asghari, S. Mohsen
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2018, 38 (5-6) : 432 - 441
  • [10] AML Depends on VEGFR1 and Not VEGFR2 for Proliferation and Protection From Chemotherapy
    Bais, Swarna
    Wise, Elizabeth
    Harris, Eric M.
    Meacham, Amy
    Cogle, Christopher R.
    BLOOD, 2011, 118 (21) : 1535 - 1536